StockData
Aclarion, Inc. logo

Aclarion, Inc. (ACONW) stock

ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30
$0.02+0.00 (0.00%)

Close on Oct 30, 2026Market cap $5.62MP/E –Yield –

Earnings

Aclarion's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Aclarion's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2023ended Dec 31, 2023Feb 21, 2024during market hours–––Release
Q2 FY2023ended Jun 30, 2023Aug 25, 2023during market hours–––Release
Q1 FY2023ended Mar 31, 2023May 16, 2023during market hours–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Aclarion has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Aclarion puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Aclarion filed with the SEC as exhibits to Form 8-K or 6-K